TLR cross-talk confers specificity to innate immunity

International Reviews of Immunology

Volumn 33, Issue 6, 2014, Pages 443-453

  Tan, Rebecca S T ^a   Ho, Bow ^b   Leung, Bernard P ^b   Ding, Jeak L ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cytokines; Macrophage; Pathogen recognition; Signaling cross talk; Toll like receptors

Indexed keywords

C TYPE LECTIN RECEPTOR; CYTOKINE; INTERLEUKIN 1BETA; LECTIN RECEPTOR; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; RIG LIKE RECEPTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; LIGAND;

ADAPTIVE IMMUNITY; ANTIBODY SPECIFICITY; BIODIVERSITY; CELL ACTIVATION; CELL INTERACTION; CELL STIMULATION; CROSS REACTION; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENZYME INHIBITION; GENETIC VARIABILITY; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INNATE IMMUNITY; MACROPHAGE; PROTEIN INTERACTION; REDUNDANCY ANALYSIS; REGULATORY MECHANISM; REVIEW; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; AGONISTS; ANIMAL; IMMUNOLOGY; METABOLISM;

ANIMALS; CYTOKINES; HUMANS; IMMUNITY, INNATE; LIGANDS; MACROPHAGES; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84911419340     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830185.2014.921164     Document Type: Review

References (57)

1. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010;327:291-295.
2. Eisen HN, Chakraborty AK. Evolving concepts of specifcity in immune reactions. Proc Natl Acad Sci USA 2010;107:22373-22380.
3. Wooldridge L, Ekeruche-Makinde J, van den Berg HA, et al. A single autoimmune T cell receptor recognizes more than a million diferent peptides. J Biol Chem 2012;287:1168-1177.
4. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004;430:257-263.
5. Kurtz J. Specifc memory within innate immune systems. Trends Immunol 2005;26:186-192.
6. Vivier E, Malissen B. Innate and adaptive immunity: specifcities and signaling hierarchies revisited. Nat Immunol 2005;6:17-21.
7. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045.
8. Fontana MF, Vance RE. Two signal models in innate immunity. Immunol Rev 2011; 243: 26-39.
9. Arstila TP, Casrouge A, Baron V, et al. A direct estimate of the human alphabeta T cell receptor diversity. Science 1999;286:958-961.
10. Underhill DM. Collaboration between the innate immune receptors dectin-1, TLRs, and Nods. Immunol Rev 2007;219:75-87.
11. Delaloye J, Roger T, Steiner-Tardivel QG, et al. Innate immune sensing of modifed vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 infammasome. PLoS Pathog 2009;5:e1000480.
12. Slater L, Bartlett NW, Haas JJ, et al. Co-ordinatedroleofTLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog 2010;6:e1001178.
13. Ferwerda G, Kullberg BJ, de Jong DJ, et al. Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2. J Leukoc Biol 2007;82:1011-1018.
14. Negishi H, Yanai H, Nakajima A, et al. Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses. Nat Immunol 2012;13:659-666.
15. Bender VA, Bender KJ, Brasier DJ, Feldman DE. Two coincidence detectors for spike timing-dependent plasticity in somatosensory cortex. J Neurosci 2006;26:4166-4177.
16. Netea MG, Nold-Petry CA, Nold MF, et al. Diferential requirement for the activation of the infammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 2009;113:2324-2335.
17. Lindsay RW, Darrah PA, Quinn KM, et al. CD8+ T cell responses following replication-defective ade-novirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling. J Immunol 2010;185:1513-1521.
18. Ku CL, von Bernuth H, Picard C, et al. Selective predisposition to bacterial infections in IRAK-4-defcient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med 2007;204:2407-2422.
19. Nish S, Medzhitov R. Host defense pathways: role of redundancy and compensation in infectious disease phenotypes. Immunity 2011;34:629-636.
20. Arkwright PD, Abinun M, Cant AJ. Autoimmunity in human primary immunodefciency diseases. Blood 2002;99:2694-2702.
21. Dennehy KM, Ferwerda G, Faro-Trindade I, et al. Syk kinase is required for collaborative cy-tokine production induced through Dectin-1 and Toll-like receptors. Eur J Immunol 2008;38: 500-506.
22. Dennehy KM, Willment JA, Williams DL, Brown GD. Reciprocal regulation of IL-23 and IL-12 following co-activation of Dectin-1 and TLR signaling pathways. Eur J Immunol 2009;39:1379-1386.
23. Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 2007;7:454-465.
24. Rothlin CV, Ghosh S, Zuniga EI, et al. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 2007;131:1124-1136.
25. Meyer-Wentrup F, Cambi A, Joosten B, et al. DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production. J Leukoc Biol 2009;85:518-525.
26. Johnson AC, Li X, Pearlman E. MyD88 functions as a negative regulator of TLR3/TRIF-induced corneal infammation by inhibiting activation of c-Jun N-terminal kinase. J Biol Chem 2008;283:3988-3996.
27. Siednienko J, Gajanayake T, Fitzgerald KA, et al. Absence of MyD88 results in enhanced TLR3-dependent phosphorylation of IRF3 and increased IFN-beta and RANTES production. J Immunol 2011;186:2514-2522.
28. Crozat K, Vivier E, Dalod M. Crosstalk between componentsof the innate immunesystem: promoting anti-microbial defenses and avoiding immunopathologies. Immunol Rev 2009;227:129-149.
29. Ishii KJ, Koyama S, Nakagawa A, et al. Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 2008;3:352-363.
30. Mukhopadhyay S, Herre J, Brown GD, Gordon S. The potential for Toll-like receptors to collaborate with other innate immune receptors. Immunology 2004;112:521-530.
31. Netea MG, Van der Meer JW, Sutmuller RP, et al. From the T1/T2 paradigm towards a Toll-like receptor/T-helper bias. Antimicrob Agents Chemother 2005;49:3991-3996.
32. Agrawal S, Agrawal A, Doughty B, et al. Cutting edge: diferent Toll-like receptor agonists instruct dendritic cells to induce distinct T responses via diferential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 2003;171:4984-4989.
33. Sato S, Nomura F, Kawai T, et al. Synergy and cross-tolerance between toll-like receptor (TLR) 2-and TLR4-mediated signaling pathways. J Immunol 2000;165:7096-7101.
34. De Nardo D, De Nardo CM, Nguyen T, et al. Signalingcrosstalk duringsequential TLR4 and TLR9acti-vation amplifes the infammatory response of mouse macrophages. J Immunol 2009;183:8110-8118.
35. Teiner G, Rossner S, Dalpke A, et al. TLR9 cooperates with TLR4 to increase IL-12 release by murine dendritic cells. Mol Immunol 2008;45:244-252.
36. Napolitani G, Rinaldi A, Bertoni F, et al. Selected Toll-like receptor agonist combinations syn-ergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol 2005;6: 769-776.
37. Zhu Q, Egelston C, Vivekanandhan A, et al. Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines. Proc Natl Acad Sci USA 2008;105:16260-16265.
38. Zhu Q, Egelston C, Gagnon S, et al. Using 3 TLR ligands as a combination adjuvant inducesqualitative changes in T cell responses needed for antiviral protection in mice. J Clin Invest 2010;120:607-616.
39. Piao W, Song C, Chen H, et al. Endotoxin tolerance dysregulates MyD88-and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling. J Leukoc Biol 2009;86:863-875.
40. de Vos AF, Pater JM, van den Pangaart PS, et al. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands. J Immunol 2009;183:533-542.
41. Wenink MH, Santegoets KC, Broen JC, et al. TLR2 promotes T2/T17 responses via TLR4 and TLR7/8 by abrogating the type I IFN amplifcation loop. J Immunol 2009;183:6960-6970.
42. Sato A, Linehan MM, Iwasaki A. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Natl Acad Sci USA 2006;103:17343-17348.
43. Bagchi A, Herrup EA, Warren HS, et al. MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. J Immunol 2007;178:1164-1171.
44. Ouyang X, Negishi H, Takeda R, et al. Cooperation between My D88 and TRIF pathways in TLR synergy via IRF5 activation. Biochem Biophys Res Commun 2007;354:1045-1051.
45. Arpaia N, Godec J, Lau L, et al. TLR signaling is required for salmonella typhimurium virulence. Cell 2011;144:675-688.
46. Gautier G, Humbert M, Deauvieau F, et al. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med 2005;201:1435-1446.
47. Malissen B, Ewbank JJ. 'TaiLoRing' the response of dendritic cells to pathogens. Nat Immunol 2005;6:749-750.
48. Krummen M, Balkow S, Shen L, et al. Release of IL-12 by dendritic cells activated by TLR ligation is dependent on MyD88 signaling, whereas TRIF signaling is indispensable for TLR synergy. J Leukoc Biol 2010;88:189-199.
49. Rathinam Vijay AK, Vanaja Sivapriya K, Waggoner L, et al. TRIF Licenses Caspase-11-Dependent NLRP3 Infammasome Activation by Gram-Negative Bacteria. Cell 2012;150:606-619.
50. Petricevic B, Wessner B, Sachet M, et al. CL097, a TLR7/8 ligand, inhibits TLR-4-dependent activation of IRAK-M and BCL-3 expression. Shock 2009;32:484-490.
51. Lang R, Hammer M, Mages J. DUSP meet immunology: dual specifcity MAPK phosphatases in control of the infammatory response. J Immunol 2006;177:7497-7504.
52. Jefrey KL, Camps M, Rommel C, Mackay CR. Targeting dual-specifcity phosphatases: manipulating MAP kinase signalling and immune responses. Nat Rev Drug Discov 2007;6:391-403.
53. Tross D, Petrenko L, Klaschik S, Zhu Q, Klinman DM. Global changes in gene expression and syner-gistic interactions induced by TLR9 and TLR3. Mol Immunol 2009;46:2557-2564.
54. Tan S, Lin B, Liu Q, et al. The synergy in cytokine production through MyD88-TRIF pathways is coordinated with ERK phosphorylation in macrophages. Immunol Cell Biol 2013;91:377-387.
55. Bohnenkamp HR, Papazisis KT, Burchell JM, Taylor-Papadimitriou J. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses. Cell Immunol 2007;247:72-84.
56. Mäkelä SM, Strengell M, Pietilä TE, et al. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells. J Leukoc Biol 2009;85:664-672.
57. Hirata N, Yanagawa Y, Ebihara T, et al. Selective synergy in anti-infammatory cytokine production upon cooperated signaling via TLR4 and TLR2 in murine conventional dendritic cells. Mol Immunol 2008;45:2734-2742.